Carmoterol
- Generic Name
- Carmoterol
- Drug Type
- Small Molecule
- Chemical Formula
- C21H24N2O4
- CAS Number
- 147568-66-9
- Unique Ingredient Identifier
- 9810NUL4D1
- Associated Conditions
- Asthma, Bronchoconstriction, Chronic Bronchitis, Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD
Phase 2
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- First Posted Date
- 2008-03-21
- Last Posted Date
- 2010-08-27
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 57
- Registration Number
- NCT00640484
- Locations
- 🇺🇸
Spartanburg Medical Research, Spartanburg, South Carolina, United States
🇺🇸UCLA David Geffen School of Medicine, Los Angeles, California, United States
🇺🇸Horizon Clinical Research Associates, PLLC, Gilbert, Arizona, United States
Dose Finding Study of CHF 4226 for Treating Patients With COPD
Phase 2
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- First Posted Date
- 2008-01-31
- Last Posted Date
- 2017-04-11
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 278
- Registration Number
- NCT00605891
- Locations
- 🇨🇿
Ordinace pro nemoci dychaciho ustroji, Beroun, Czech Republic
🇺🇸University Clinical Research - DeLand, LLC, DeLand, Florida, United States
🇵🇱NZOZ Non-nocere, Gdansk, Poland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath